United States· US:59726-740_d1b27e2d-8ea9-4871-bfa2-89463ae0dee0
Omeprazole
A omeprazole product containing omeprazole, registered in United States by P & L Development, LLC. The same ATC class is registered in 19 of our 19 countries.
Checked against FDA National Drug Code directory (United States) on
Informational only — not a medical device.
Where it is registered
Omeprazole is registered in 19 of 19 countries.
Countries holding a registration under ATC A02BC01 (omeprazole), each read from that country’s own register.
- This record: United States, from FDA National Drug Code directory (United States)
- 11 of them publish a price we can compare per daily dose
Omeprazole · ATC A02BC01
19 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Franceprice
- Germany
- Icelandprice
- Ireland
- Italyprice
- Japan
- Netherlands
- Norwayprice
- Polandprice
- Spainprice
- Sweden
- Switzerlandprice
- United Kingdom
- United Statesprice
Price per daily dose
What a daily dose of omeprazole costs, country by country.
Normalised to the WHO defined daily dose (20 mg), the median price runs from $0.10 in Spain to $1.17 in Switzerland — a ×12 gap.
- 3 markets with a comparable price for this class
- Public list prices, converted to USD at the rate date shown
Omeprazole · price per daily dose (20 mg)
USD · FX 28 Sept 2026
- CH Switzerland$1.17
- IT Italy$0.46
- ES Spain$0.10
The record
At a glance
FDA National Drug Code directory (United States)- Active substance
- Omeprazole
- Manufacturer
- P & L Development, LLC
- Country
- United States (US)
- ATC code
- A02BC01
- ATC class
- Omeprazole
- Defined daily dose
- 20 mg, O
- Reimbursed
- Not published by this register
- Source register
- FDA National Drug Code directory (United States)
- Last checked
- September 12, 2026
Packs & prices · 1
- ndc1159726740423 BOTTLE, PLASTIC in 1 BOX (59726-740-42) / 14 TABLET, DELAYED RELEASE in 1 BOTTLE, PLASTIC
Regulatory notes
Interactions
802 interactions on record for omeprazole.
Graded by severity as the source publishes them — 25 severe. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Omeprazole · interactions on record
802 records
- 25 severe
- 136 moderate
- 62 minor
- 568 info
Most severe, free to view
- ClopidogrelB01AC04severe
- CilostazolB01AC23severe
- NelfinavirJ05AE04severe
- AtazanavirJ05AE08severe
11 more interactions with mechanism and management, from a commercially licensed source.
Sign in to check- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same medicine, other countries
Omeprazole in 16 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- United KingdomLosec MUPS 20mg gastro-resistant tabletsSigma Pharmaceuticals Plc
- CanadaACH-OMEPRAZOLEACCORD HEALTHCARE INC
- NetherlandsLosec MUPS 20 mg, maagsapresistente tablettenCHEPLAPHARM Arzneimittel GmbH
- FinlandLosecBayer Oy
- BelgiumLosec-Mups 20 mgCheplapharm Arzneimittel
- IrelandLosec Control 20 mg gastro-resistant tabletsBayer Limited
- NorwayLosec Mups2care4 ApS
- SwedenLosec 20 mg EnterotablettCheplapharm Arzneimittel GmbH
Authorised across Europe · EMA
The same active substance is authorised in 30 EEA countries. Names it is sold under:
- Austria · Losec, Omec
- Belgium · Acidcare, Lappoxo
- Bulgaria · Probitor, Биопразол
- Cyprus · Ezipol, Medoprazole
- Czechia · Helicid, Helicid Neo
- Germany · Antra Mups, Gastrobin Protect
- Denmark · Lappoxo, Losec
- Estonia · Gasec Gastrocaps, Lappoxo
- Spain · Arapride, Aulcer
- Finland · Losec, Losec Mups
- France · Arpemix, Mopral
- United Kingdom (Northern Ireland) · Aylome, Boots One-A-Day Acid Reflux Relief
- Greece · Alevior, Assoprol
- Croatia · Lappoxo, Ortalox
- Hungary · Helant, Lappoxo
- Ireland · Appizped, Losec Control
- Iceland · Omeprazol Actavis, Omeprazol Medical Valley
- Italy · Anadir, Antra
- Lithuania · Gasec, Lappoxolo
- Luxembourg · Losec-Mups, Omeprazol Nt Ratiopharm
- Latvia · Gasec Gastrocaps, Lappoxo
- Malta · Losec Control, Losec Mups
- Netherlands · Appizmit, Kruidvat Maagzuurremmer
- Norway · Lappoxo, Losec Mups
- Poland · Agastin 20 Mg, Apteo Med
- Portugal · Albosan, Gasec
- Romania · Helant, Lappoxo
- Sweden · Appizmit, Helicid
- Slovenia · Lappoxo, Ortanol
- Slovakia · Helicid, Helicid Neo
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FDA National Drug Code directory (United States). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/d174135e-3cf8-45f1-98a7-2d116b439fbe GET /v1/drugs/d174135e-3cf8-45f1-98a7-2d116b439fbe?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"unii": {
"unii": "426QFE7XLK",
"rxcui": "236486",
"inchikey": "KWORUUGOSLYAGD-UHFFFAOYSA-N",
"display_name": "OMEPRAZOLE MAGNESIUM",
"substance_type": "chemical",
"ingredient_type": "INGREDIENT SUBSTANCE"
},
"route": "ORAL",
"livertox": {
"summary": null,
"livertox_id": null,
"hepatotoxicity_score": 2
},
"spl_meta": {
"b3ec4a44-5643-4438-b41b-e04946436719": {
"match": "brand_token",
"title": "OMEPRAZOLE CAPSULE, DELAYED RELEASE [SAFEWAY]",
"spl_version": "3",
"published_date": "2026-05-29"
}
},
"productid": "59726-740_d1b27e2d-8ea9-4871-bfa2-89463ae0dee0",
"productndc": "59726-740",
"dosage_form": "TABLET, DELAYED RELEASE",
"orange_book": {
"appl_no": "206582",
"products": [
{
"rs": false,
"rld": false,
"te_code": null,
"strength": "EQ 20MG BASE",
"product_no": "001",
"approval_date": "Jun 1, 2020"
}
],
"appl_type": "A"
},
"dea_schedule": null,
"product_type": "HUMAN OTC DRUG",
"substance_name": "OMEPRAZOLE MAGNESIUM",
"shortage_reason": "Omeprazole Delayed Release Capsule",
"shortage_status": "current",
"proprietary_name": "Omeprazole",
"active_ingred_unit": "mg/1",
"application_number": "ANDA206582",
"marketing_category": "ANDA",
"nonproprietary_name": "Omeprazole",
"start_marketing_date": "20250815",
"active_numerator_strength": "20"
}See everything about omeprazole.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.